SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-19-019361
Filing Date
2019-12-17
Accepted
2019-12-17 16:15:17
Documents
1
Period of Report
2019-12-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 26818
  Complete submission text file 0001493152-19-019361.txt   28162
Mailing Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-13789 | Film No.: 191289884
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences